JACOBS LEVY EQUITY MANAGEMENT, INC - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 112 filers reported holding INSYS THERAPEUTICS INC NEW in Q4 2017. The put-call ratio across all filers is 1.10 and the average weighting 0.0%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q4 2018$279,000
+114.6%
79,700
+444.4%
0.01%
+66.7%
Q3 2017$130,000
-35.3%
14,640
-23.3%
0.00%
-25.0%
Q1 2017$201,000
-71.4%
19,080
+12.6%
0.00%
-66.7%
Q1 2014$702,000
+12.7%
16,950
+5.3%
0.01%
+33.3%
Q4 2013$623,000
+83.8%
16,090
+65.9%
0.01%
+50.0%
Q3 2013$339,0009,7000.01%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q4 2017
NameSharesValueWeighting ↓
Orbimed Advisors 5,406,844$52,014,0000.66%
ETF MANAGERS GROUP, LLC 282,268$3,255,0000.24%
Mirae Asset Global Investments Co., Ltd. 1,470,996$14,151,0000.19%
Financial Gravity Companies, Inc. 4,467$42,0000.05%
GSA CAPITAL PARTNERS LLP 67,200$646,0000.04%
TCI Wealth Advisors, Inc. 7,766$75,0000.03%
Freedom Investment Management, Inc. 64,741$623,0000.03%
GAM Holding AG 83,940$808,0000.02%
SFMG, LLC 11,994$115,0000.02%
SHELL ASSET MANAGEMENT CO 95,127$915,0000.02%
View complete list of INSYS THERAPEUTICS INC NEW shareholders